Subscribe to Newsletter

Business & Regulation

 Business & Regulation Business Practice

This Week’s Biopharma News: RFK Jr Selects New Members for US Vaccine Committee

| 4 min read

Our latest news roundup reports on a new RSV FDA approval for Moderna, payment hikes in the UK, and calls in the US for a ban on direct-to-consumer advertising.

Business & Regulation Advanced Medicine

Gene Therapy Successes in Ophthalmology

| Daniel Eisenman, James Riddle | 8 min read

Ophthalmology is quietly becoming gene therapy’s next big frontier. Here’s how the science, the patients, and the regulations are aligning.
Business & Regulation Standards & Regulation

FDA Plans for Shorter Drug Reviews

| Kerri Miller | 2 min read

Martin A. Makary and Vinay Prasad write that “rapid or instant reviews” could be possible at the FDA.
Business & Regulation Standards & Regulation

RFK Jr Fires CDC Vaccine Advisory Committee

| Stephanie Vine | 3 min read

All 17 members removed from advisory panel, with RFJ Jr claiming it is “plagued with conflict of interest.”
Business & Regulation Business Practice

This Week’s Biopharma News: Argentina’s WHO Exit and Sanofi Acquisition of Blueprint Medicines

| Rob Coker | 4 min read

Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.
Business & Regulation Advanced Medicine

Preparing National Strategies for CAR T: The Latest IQVIA Report

| Rob Coker | 5 min read

The IQVIA Institute’s latest report evaluates how well seven countries are prepared to support the complex infrastructure required for CAR T therapies
Business & Regulation Business Practice

AI or Tradition: The Great Pharma Sales Dilemma

| 3 min read

Pharma sales teams are under pressure, but traditional training models aren’t keeping up. Can AI help?
Business & Regulation Bioprocessing - Upstream & Downstream

Trump Administration Cans Bird Flu Vaccine Contract With Moderna

| Rob Coker | 3 min read

From bird flu to COVID-19 vaccines to alleged corruption in journals, we look into recent moves from US Health Secretary RFK Jr.
Business & Regulation Business Practice

This Week’s Biopharma News: Pfizer and Astellas Drug Improves Cancer Survival

| Rob Coker | 4 min read

Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.
Business & Regulation Business Practice

Behind the Scenes of a GMP Win

| 4 min read

We ask a company about lessons learned from the GMP certification process.
Business & Regulation Business Practice

The New Age of Global, Political, and Regulatory Challenges

| 7 min read

A report attempts to unravel the many challenges that face business leaders. We discuss those inherent in the pharmaceutical industry.
Business & Regulation Business Practice

What Trump’s Latest Moves Mean for the Industry

| 6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”
Business & Regulation Standards & Regulation

This Week’s Industry News: Changes at the top of Novo Nordisk

| 3 min read

Our latest news roundup reports on changes at Novo Nordisk, AbbVie’s ADC accelerated approval, Regeneron’s new acquisition, and more.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker